The Chosun Ilbo on MSN
FDA Speeds Up Custom Gene Therapy Approvals With Existing Data
Last May, people were thrilled to learn that a 7-month-old baby who became the first in the world to receive a personalized ...
Hosted on MSN
Ocugen’s Phase 3 Gene Therapy Trial: A Potential Game-Changer for Retinitis Pigmentosa
Ocugen Inc. is currently conducting a Phase 3 clinical study titled ‘A Phase 3, Multi-Center, Randomized Study to Assess The Efficacy, Safety and Tolerability of Subretinal OCU400 Gene Therapy for the ...
Background Fabry disease (FD) is an X linked lysosomal disorder with ventricular myocardial involvement that drives morbidity and mortality. Early diagnosis of cardiac involvement can be difficult.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback